PepGen Inc. (PEPG)
NASDAQ: PEPG · Real-Time Price · USD
5.69
+0.17 (3.18%)
At close: Mar 6, 2026, 4:00 PM EST
5.77
+0.08 (1.41%)
After-hours: Mar 6, 2026, 7:25 PM EST
PepGen Employees
PepGen had 81 employees as of December 31, 2024. The number of employees increased by 17 or 26.56% compared to the previous year.
Employees
81
Change (1Y)
17
Growth (1Y)
26.56%
Revenue / Employee
n/a
Profits / Employee
-$1,572,895
Market Cap
390.83M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 81 | 17 | 26.56% |
| Dec 31, 2023 | 64 | 19 | 42.22% |
| Dec 31, 2022 | 45 | 14 | 45.16% |
| Dec 31, 2021 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| REGENXBIO | 353 |
| 4D Molecular Therapeutics | 227 |
| Entrada Therapeutics | 152 |
| Enanta Pharmaceuticals | 120 |
| Solid Biosciences | 100 |
| Invivyd | 100 |
| Verastem | 78 |
| Lineage Cell Therapeutics | 77 |
PEPG News
- 1 day ago - PepGen Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 2 days ago - US FDA puts partial clinical hold on PepGen's muscle disease drug trial - Reuters
- 2 days ago - PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights - Business Wire
- 2 days ago - PepGen Announces Regulatory Updates on FREEDOM2 - Business Wire
- 4 days ago - PepGen to Participate in the Leerink Global Healthcare Conference - Business Wire
- 3 months ago - PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer - Business Wire
- 3 months ago - PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer - Business Wire
- 4 months ago - PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule - Business Wire